Quoin Pharmaceuticals (QNRX) Shares Outstanding (2017 - 2026)

Quoin Pharmaceuticals has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $2.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 382.83% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (up 382.83% YoY) and the FY2025 annual result came in at $1.1 million, up 355.63% from the prior year.
• Shares Outstanding (Entity) grew to $2.8 million in Q1 2026 per QNRX's latest filing, from $1.1 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $2.8 million in Q1 2026 and troughed at $1.0 in Q2 2023.
• A 5-year average of $388544.7 and a median of $105165.0 in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) sank 98.09% in 2022, then surged 25248500.0% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $29.0 in 2022, then jumped by 170110.34% to $49361.0 in 2023, then soared by 374.94% to $234436.0 in 2024, then jumped by 355.63% to $1.1 million in 2025, then soared by 165.03% to $2.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $2.8 million, $1.1 million, and $588166.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.